Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
See below for the Latest Gilead Sciences News, Analysis, Profit Results, Share Price Information, and Commentary.
Data privacy amongst obstacles for using telehealth on HIV treatment in APAC
Data privacy amongst obstacles for using telehealth on HIV treatment in APAC
Almost half of people living with HIV are concerned about cybersecurity.
Using offline and online channels to counter misperceptions of hepatitis B – a ‘silent disease’ – in Singapore
Gilead Sciences’ US$1m grant will help NFDD and other community-based organisations across Asia battle public apathy towards liver disease.
Gilead Sciences names its new health leader for Asia markets
Dustin Haines has 20 years leadership in pharmaceuticals.
Me & My Healthcare Provider targets HIV’s ‘Achilles heel’
The International AIDS Society and Gilead Sciences partner to promote stigma-free HIV care in Asia.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. Global pharmaceutical data and analytics market to double by 2028 3. ASEAN medical tourism set to outpace global revenue growth 4. Australia announces $25.5m 2024 Rapid Applied Research Translation grant 5. Thomson and Monash University Malaysia partner for joint researchResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
